Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11306447

Cancer Res. 2001 Apr 1 61 7 2804-8

Download in:

View as

General Info

PMID
11306447